Anti-inflammatory supplements 2026 — curcumin, omega-3, tart cherry, boswellia and the CRP claim, reviewed

What it claims

• 'Reduces chronic inflammation at the source', 'lowers CRP'
• 'Joint comfort in 7 days' — curcumin, boswellia and the joint stacks
• 'Faster recovery, less muscle soreness' — tart cherry and omega-3
• 'Resolves inflammation rather than blocking it' — the SPM positioning
• 'Clinically studied ingredient' — usually true of the ingredient, rarely true of the dose in the capsule

What the label is not telling you

• Plain turmeric powder in a capsule is close to useless orally. Curcumin has notoriously poor solubility, rapid glucuronidation and minimal systemic bioavailability. The trials that show effects almost always use an engineered form — Meriva (phytosome), Theracurmin (nano-dispersed), BCM-95, or curcumin co-dosed with piperine — at doses of roughly 500–2,000 mg/day of actual curcuminoids. A '1,500 mg turmeric root' capsule with no delivery system and no standardisation is not the product that was studied. Where the delivery is right, the osteoarthritis pain data is reasonable and repeatable (Daily 2016 meta-analysis; multiple Meriva knee-OA trials), with effect sizes in the range of a low-dose NSAID and a much friendlier GI profile.
• Omega-3 is the best-evidenced item on the shelf, and the dose most people take is too low. EPA/DHA at 2–4 g/day lowers triglycerides reliably and reduces inflammatory markers in several populations; the high-dose icosapent-ethyl cardiovascular data (REDUCE-IT, 2019) sits at 4 g/day of a purified EPA. A standard 1,000 mg 'fish oil' softgel typically contains 300 mg of combined EPA+DHA — you would need six to ten of them to reach trial dose. Read the EPA+DHA line, not the capsule weight. Oxidation is the other quiet problem: independent testing repeatedly finds rancid fish oil on shelves, and oxidised omega-3 is pro-inflammatory, which is the exact opposite of the purchase.
• CRP is a real marker, and almost nobody buying these products has measured theirs. High-sensitivity CRP is a cheap, widely available blood test. Without a baseline and a repeat, 'it lowered my inflammation' is a feeling, not a finding. If inflammation is the thesis, measure hs-CRP, and consider ferritin and fasting insulin alongside it — metabolic and inflammatory load travel together.
• Tart cherry has decent, narrow data. Concentrate at roughly 30 ml twice daily around hard training shows modest reductions in soreness and functional recovery markers in several small trials (Bell; Howatson), plus a small sleep signal attributed to melatonin and tryptophan availability. It is a reasonable recovery tool for a heavy training block. It is not a treatment for systemic inflammatory disease.
• Boswellia and ginger are the credible second tier. Standardised boswellia (AKBA-standardised extracts) has repeatable, small-to-moderate knee-OA data via 5-lipoxygenase inhibition. Ginger has modest DOMS and OA signals. Both are cheap, both are safe, both are oversold in blends where the actual per-serving dose is a fraction of the studied one — the 'proprietary blend' label exists precisely so you cannot check.
• SPMs (specialised pro-resolving mediators) are genuinely interesting science and a premature product. Serhan's resolution biology is one of the most important immunology stories of the last two decades — inflammation resolution is an active programme, not a passive fade. Translating that into an over-the-counter softgel with meaningful human outcome data has not happened yet. Buying the mechanism is not buying the result.
• The two interventions with the largest effect on inflammatory markers are not on this shelf. Sleep restriction raises IL-6 and CRP within days (Irwin's body of work is unambiguous on this), and visceral adiposity is itself an endocrine source of inflammatory signalling. Regular aerobic activity and resistance training lower the same markers over months. Any supplement on this list is a rounding error next to a chronically short night — which is inconvenient, unmonetisable, and true.

Effect on the nervous system

Inflammation and the autonomic nervous system are not neighbours, they are wired together. The vagus nerve carries an afferent immune-sensing line and an efferent cholinergic anti-inflammatory pathway — Tracey's work through the 2000s showed that vagal efferent activity suppresses macrophage TNF release, which is the whole conceptual basis for the vagus-stimulation devices we reviewed separately. That gives inflammation a two-way relationship with regulation: sustained sympathetic dominance and poor vagal tone permit a higher inflammatory set-point, and circulating inflammatory cytokines in turn drive sickness behaviour — the flat, foggy, socially withdrawn, sleep-heavy state that people describe as burnout and treat as a character failure. This is why an anti-inflammatory capsule so often disappoints: it is being asked to counteract a signal the body is actively producing because the system reads its conditions as chronically unsafe. Fix the sleep window, the training-to-recovery ratio and the evening sympathetic load, and the inflammatory baseline moves without a purchase. Add curcumin and adequately dosed omega-3 on top of that, and you are accelerating something already in motion.

Who it might suit

Anyone with knee or hand osteoarthritis pain: a properly delivered curcumin (Meriva, Theracurmin, BCM-95) at studied dose, and standardised boswellia, are among the better non-drug options available. Anyone with elevated triglycerides or a measured elevated hs-CRP: 2–4 g/day EPA+DHA, from a brand that publishes oxidation values (TOTOX). Athletes in a heavy training block: tart cherry concentrate around sessions. Anyone who has actually measured a baseline and is willing to re-measure in 12 weeks.

Who should skip it

Anyone on anticoagulants or with a bleeding disorder taking high-dose omega-3, curcumin or ginger without a clinician's sign-off — all three affect platelet function. Anyone with gallbladder disease taking high-dose curcumin. Anyone treating an autoimmune diagnosis with this shelf instead of care. And anyone buying a proprietary-blend 'inflammation formula' that lists fifteen ingredients without per-ingredient doses — the maths cannot work, and the label is designed so you cannot do the maths.

Bottom line

Two things earn a place: adequately dosed omega-3 (2–4 g/day EPA+DHA, low-oxidation, published TOTOX) and a bioavailable curcumin (Meriva / Theracurmin / BCM-95 at studied dose), particularly for joint pain. Reasonable, narrow: standardised boswellia and ginger for OA and soreness; tart cherry concentrate around hard training. Not yet: SPMs — beautiful science, premature product. Skip: plain turmeric capsules, proprietary blends without per-ingredient doses, and anything promising to 'lower inflammation' without naming a marker. Then do the unglamorous part: measure hs-CRP before and twelve weeks after, protect the sleep window, and treat training and recovery as the primary intervention. The Cortisol Anchor covers the autonomic side of the inflammatory set-point, the vagus nerve device comparison covers the cholinergic pathway directly, and a Nervous System Journal is where a 12-week trial stops being a vibe and becomes data.